Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease
Introduction Patients with coronavirus disease, especially solid organ transplant recipients, are more susceptible to developing cytokine release syndrome than those with other viral infections. However, currently, treatment methods for such patients have not been established. Here, we describe two cases of successful immunomodulation in Japanese kidney transplant recipients with cytokine release syndrome following coronavirus disease. Case presentation Two patients who had been receiving long‐term immunosuppressant therapy developed coronavirus disease‐associated pneumonia caused by cytokine release syndrome, following immunosuppressant dosage reduction. However, they recovered immediately after administration of tocilizumab with or without dexamethasone. Conclusion The immunosuppressant dosage should be reduced to restore host immunity; however, immunomodulation should be considered in cases of suspected cytokine release syndrome..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
IJU Case Reports - 5(2022), 5, Seite 373-377 |
| Beteiligte Personen: |
Takamoto, Daiji [VerfasserIn] |
|---|
| Anmerkungen: |
Copyright © 2022 The Japanese Urological Association |
|---|
| Umfang: |
377 |
|---|
| doi: |
10.1002/iju5.12492 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY007408129 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY007408129 | ||
| 003 | DE-627 | ||
| 005 | 20230216084422.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/iju5.12492 |2 doi | |
| 028 | 5 | 2 | |a IJU5_IJU512492.xml |
| 035 | |a (DE-627)WLY007408129 | ||
| 035 | |a (WILEY)IJU512492 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Takamoto, Daiji |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease |
| 264 | 1 | |c 2022 | |
| 300 | |a 377 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Copyright © 2022 The Japanese Urological Association | ||
| 520 | |a Introduction Patients with coronavirus disease, especially solid organ transplant recipients, are more susceptible to developing cytokine release syndrome than those with other viral infections. However, currently, treatment methods for such patients have not been established. Here, we describe two cases of successful immunomodulation in Japanese kidney transplant recipients with cytokine release syndrome following coronavirus disease. Case presentation Two patients who had been receiving long‐term immunosuppressant therapy developed coronavirus disease‐associated pneumonia caused by cytokine release syndrome, following immunosuppressant dosage reduction. However, they recovered immediately after administration of tocilizumab with or without dexamethasone. Conclusion The immunosuppressant dosage should be reduced to restore host immunity; however, immunomodulation should be considered in cases of suspected cytokine release syndrome. | ||
| 700 | 1 | |a Sasaki, Hajime |4 aut | |
| 700 | 1 | |a Kataoka, Hiroshi |4 aut | |
| 700 | 1 | |a Kodama, Fumihiro |4 aut | |
| 700 | 1 | |a Higuchi, Haruka |4 aut | |
| 700 | 1 | |a Hirano, Tetsuo |4 aut | |
| 700 | 1 | |a Takada, Yusuke |4 aut | |
| 700 | 1 | |a Harada, Shigeru |4 aut | |
| 700 | 1 | |a Harada, Hiroshi |4 aut | |
| 700 | 1 | |a Tanaka, Hiroshi |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t IJU Case Reports |g 5(2022), 5, Seite 373-377 |w (DE-627)WLY007404409 |x 2577171X |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2022 |g number:5 |g pages:373-377 |g extent:377 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2022 |e 5 |h 373-377 |g 377 | ||